Hannah Cell Science, a division of Hannah InterActions Ltd, offers in-house analytical services focused on the cell and molecular biology of lifestyle-related diseases, including osteoporosis, diabetes and cancer. This will be complemented by Hannah Cell Science's new portfolio of cell-based assays to be launched in mid-2004. Cell-based assays will be targeted at important cell signals and criitical events in disease progression, and will offer convenient, off-the-shelf, tools for both pharmaceutical R&D and academic research use.